WO2002055561A1 - Method for surface display of proteins on genetic carriers - Google Patents
Method for surface display of proteins on genetic carriers Download PDFInfo
- Publication number
- WO2002055561A1 WO2002055561A1 PCT/KR2002/000059 KR0200059W WO02055561A1 WO 2002055561 A1 WO2002055561 A1 WO 2002055561A1 KR 0200059 W KR0200059 W KR 0200059W WO 02055561 A1 WO02055561 A1 WO 02055561A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- interest
- genetic carrier
- spore
- genetic
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 375
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 317
- 230000002068 genetic effect Effects 0.000 title claims abstract description 184
- 238000000034 method Methods 0.000 title claims abstract description 162
- 239000000969 carrier Substances 0.000 title description 4
- 239000000126 substance Substances 0.000 claims abstract description 33
- 239000013598 vector Substances 0.000 claims abstract description 33
- 241000700605 Viruses Species 0.000 claims abstract description 19
- 238000012258 culturing Methods 0.000 claims abstract description 12
- 230000001131 transforming effect Effects 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 claims description 111
- 102000004190 Enzymes Human genes 0.000 claims description 45
- 108090000790 Enzymes Proteins 0.000 claims description 45
- 229940088598 enzyme Drugs 0.000 claims description 44
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 27
- 102000014914 Carrier Proteins Human genes 0.000 claims description 27
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 27
- 108091008324 binding proteins Proteins 0.000 claims description 25
- 238000012216 screening Methods 0.000 claims description 21
- 244000063299 Bacillus subtilis Species 0.000 claims description 20
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 20
- 108010052285 Membrane Proteins Proteins 0.000 claims description 19
- 239000000427 antigen Substances 0.000 claims description 19
- 108091007433 antigens Proteins 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 18
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 17
- 241000894006 Bacteria Species 0.000 claims description 16
- -1 eglin Proteins 0.000 claims description 15
- 238000000684 flow cytometry Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 239000012634 fragment Substances 0.000 claims description 14
- 229920001184 polypeptide Polymers 0.000 claims description 14
- 125000002091 cationic group Chemical group 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 13
- 241001515965 unidentified phage Species 0.000 claims description 13
- 108091005804 Peptidases Proteins 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 11
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 11
- 239000003960 organic solvent Substances 0.000 claims description 11
- 238000002708 random mutagenesis Methods 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- 108010038807 Oligopeptides Proteins 0.000 claims description 10
- 102000015636 Oligopeptides Human genes 0.000 claims description 10
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 102000034356 gene-regulatory proteins Human genes 0.000 claims description 8
- 108091006104 gene-regulatory proteins Proteins 0.000 claims description 8
- 239000005556 hormone Substances 0.000 claims description 8
- 229940088597 hormone Drugs 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000002741 site-directed mutagenesis Methods 0.000 claims description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 239000002585 base Substances 0.000 claims description 6
- 238000002306 biochemical method Methods 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 6
- 239000003446 ligand Substances 0.000 claims description 6
- 238000002493 microarray Methods 0.000 claims description 6
- 239000000178 monomer Substances 0.000 claims description 6
- 238000000053 physical method Methods 0.000 claims description 6
- 108700012359 toxins Proteins 0.000 claims description 6
- 101710172711 Structural protein Proteins 0.000 claims description 5
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 5
- 230000003834 intracellular effect Effects 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- 210000001322 periplasm Anatomy 0.000 claims description 5
- 238000013518 transcription Methods 0.000 claims description 5
- 230000035897 transcription Effects 0.000 claims description 5
- 108090000695 Cytokines Proteins 0.000 claims description 4
- 102000004127 Cytokines Human genes 0.000 claims description 4
- 101710089384 Extracellular protease Proteins 0.000 claims description 4
- 102000016943 Muramidase Human genes 0.000 claims description 4
- 108010014251 Muramidase Proteins 0.000 claims description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 4
- 101000882917 Penaeus paulensis Hemolymph clottable protein Proteins 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 230000023555 blood coagulation Effects 0.000 claims description 4
- 230000015556 catabolic process Effects 0.000 claims description 4
- 230000007123 defense Effects 0.000 claims description 4
- 238000006731 degradation reaction Methods 0.000 claims description 4
- 239000002532 enzyme inhibitor Substances 0.000 claims description 4
- 229940125532 enzyme inhibitor Drugs 0.000 claims description 4
- 229960000274 lysozyme Drugs 0.000 claims description 4
- 239000004325 lysozyme Substances 0.000 claims description 4
- 235000010335 lysozyme Nutrition 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 230000001590 oxidative effect Effects 0.000 claims description 4
- 230000001850 reproductive effect Effects 0.000 claims description 4
- 230000019491 signal transduction Effects 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 230000009466 transformation Effects 0.000 claims description 4
- PKTAYNJCGHSPDR-JNYFXXDFSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(1R,4S,5aS,7S,10S,11aS,13S,17aS,19R,20aS,22S,23aS,25S,26aS,28S,34S,40S,43S,46R,51R,54R,60S,63S,66S,69S,72S,75S,78S,81S,84S,87S,90S,93R,96S,99S)-51-[[(2S,3R)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-81,87-bis(2-amino-2-oxoethyl)-84-benzyl-22,25,26a,28,66-pentakis[(2S)-butan-2-yl]-75,96-bis(3-carbamimidamidopropyl)-20a-(2-carboxyethyl)-7,11a,13,43-tetrakis[(1R)-1-hydroxyethyl]-63,78-bis(hydroxymethyl)-10-[(4-hydroxyphenyl)methyl]-4,23a,40,72-tetramethyl-99-(2-methylpropyl)-a,2,5,6a,8,9a,11,12a,14,17,18a,20,21a,23,24a,26,27a,29,35,38,41,44,52,55,61,64,67,70,73,76,79,82,85,88,91,94,97-heptatriacontaoxo-69,90-di(propan-2-yl)-30a,31a,34a,35a,48,49-hexathia-1a,3,6,7a,9,10a,12,13a,15,18,19a,21,22a,24,25a,27,28a,30,36,39,42,45,53,56,62,65,68,71,74,77,80,83,86,89,92,95,98-heptatriacontazaheptacyclo[91.35.4.419,54.030,34.056,60.0101,105.0113,117]hexatriacontahectane-46-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-4-amino-4-oxobutanoic acid Chemical compound CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N2)[C@@H](C)O PKTAYNJCGHSPDR-JNYFXXDFSA-N 0.000 claims description 3
- 108010007337 Azurin Proteins 0.000 claims description 3
- 108010023798 Charybdotoxin Proteins 0.000 claims description 3
- 101710136772 Crambin Proteins 0.000 claims description 3
- 102000015833 Cystatin Human genes 0.000 claims description 3
- 101710146739 Enterotoxin Proteins 0.000 claims description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 3
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 3
- 108010064983 Ovomucin Proteins 0.000 claims description 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 3
- 102000006382 Ribonucleases Human genes 0.000 claims description 3
- 108010083644 Ribonucleases Proteins 0.000 claims description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 3
- 230000004520 agglutination Effects 0.000 claims description 3
- 108050003126 conotoxin Proteins 0.000 claims description 3
- CNVQLPPZGABUCM-LIGYZCPXSA-N ctx toxin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]3CSSC[C@@H](C(N[C@@H](CC=4C5=CC=CC=C5NC=4)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC3=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CO)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3NC=NC=3)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N2)C(C)C)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC1=O)=O)CCSC)C(C)C)[C@@H](C)O)NC(=O)[C@H]1NC(=O)CC1)C1=CC=CC=C1 CNVQLPPZGABUCM-LIGYZCPXSA-N 0.000 claims description 3
- 108050004038 cystatin Proteins 0.000 claims description 3
- 239000000147 enterotoxin Substances 0.000 claims description 3
- 231100000655 enterotoxin Toxicity 0.000 claims description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 3
- 102000003390 tumor necrosis factor Human genes 0.000 claims description 3
- 241000194107 Bacillus megaterium Species 0.000 claims description 2
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 2
- 241000193403 Clostridium Species 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 241000179039 Paenibacillus Species 0.000 claims description 2
- 108020005091 Replication Origin Proteins 0.000 claims description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 108700026220 vif Genes Proteins 0.000 claims description 2
- 102400000368 Surface protein Human genes 0.000 claims 4
- 239000000463 material Substances 0.000 claims 2
- 108010085318 carboxymethylcellulase Proteins 0.000 description 40
- 102000004882 Lipase Human genes 0.000 description 20
- 108090001060 Lipase Proteins 0.000 description 20
- 239000004367 Lipase Substances 0.000 description 20
- 235000019421 lipase Nutrition 0.000 description 20
- 230000002209 hydrophobic effect Effects 0.000 description 18
- 241000588724 Escherichia coli Species 0.000 description 17
- 238000005516 engineering process Methods 0.000 description 15
- 102000018697 Membrane Proteins Human genes 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 13
- 108010076504 Protein Sorting Signals Proteins 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 230000004927 fusion Effects 0.000 description 11
- 230000003248 secreting effect Effects 0.000 description 11
- 101710132601 Capsid protein Proteins 0.000 description 10
- 101710094648 Coat protein Proteins 0.000 description 10
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 10
- 101710125418 Major capsid protein Proteins 0.000 description 10
- 101710141454 Nucleoprotein Proteins 0.000 description 10
- 101710083689 Probable capsid protein Proteins 0.000 description 10
- 108020001507 fusion proteins Proteins 0.000 description 10
- 102000037865 fusion proteins Human genes 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 238000003498 protein array Methods 0.000 description 9
- 230000028327 secretion Effects 0.000 description 9
- 230000035899 viability Effects 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- MIKKOBKEXMRYFQ-WZTVWXICSA-N meglumine amidotrizoate Chemical compound C[NH2+]C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I MIKKOBKEXMRYFQ-WZTVWXICSA-N 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000006916 protein interaction Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- 101710116435 Outer membrane protein Proteins 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000000890 antigenic effect Effects 0.000 description 5
- 108010063679 ice nucleation protein Proteins 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 235000019626 lipase activity Nutrition 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 238000011426 transformation method Methods 0.000 description 5
- 230000032258 transport Effects 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 241000589516 Pseudomonas Species 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 230000028070 sporulation Effects 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 241001646716 Escherichia coli K-12 Species 0.000 description 3
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 230000002788 anti-peptide Effects 0.000 description 3
- 238000010170 biological method Methods 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000276408 Bacillus subtilis subsp. subtilis str. 168 Species 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- 102000009016 Cholera Toxin Human genes 0.000 description 2
- 108010049048 Cholera Toxin Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 235000019687 Lamb Nutrition 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 2
- 108090000157 Metallothionein Proteins 0.000 description 2
- 102000003792 Metallothionein Human genes 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000009391 cell specific gene expression Effects 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 101150037486 cotC gene Proteins 0.000 description 2
- 101150100043 cotD gene Proteins 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 239000006457 gys medium Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000011565 manganese chloride Substances 0.000 description 2
- 235000002867 manganese chloride Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 238000004091 panning Methods 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 230000001902 propagating effect Effects 0.000 description 2
- 230000026447 protein localization Effects 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102000006996 Aryldialkylphosphatase Human genes 0.000 description 1
- 108010008184 Aryldialkylphosphatase Proteins 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 101100000066 Brassica oleracea var. italica 1AP1 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 101710168515 Cell surface glycoprotein Proteins 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 108010040721 Flagellin Proteins 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 241000709701 Human poliovirus 1 Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 101150021155 LIP2 gene Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 108010036940 Levansucrase Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000863420 Myxococcus Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108010079246 OMPA outer membrane proteins Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 101710178358 Peptidoglycan-associated lipoprotein Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 102000017033 Porins Human genes 0.000 description 1
- 108010013381 Porins Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 101710099182 S-layer protein Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 108010008038 Synthetic Vaccines Proteins 0.000 description 1
- 241000588902 Zymomonas mobilis Species 0.000 description 1
- 230000009824 affinity maturation Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 101150069229 cwlD gene Proteins 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000010435 extracellular transport Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 231100000171 higher toxicity Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- WYMSBXTXOHUIGT-UHFFFAOYSA-N paraoxon Chemical compound CCOP(=O)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 WYMSBXTXOHUIGT-UHFFFAOYSA-N 0.000 description 1
- 229960004623 paraoxon Drugs 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- LJCNRYVRMXRIQR-UHFFFAOYSA-L potassium sodium tartrate Chemical compound [Na+].[K+].[O-]C(=O)C(O)C(O)C([O-])=O LJCNRYVRMXRIQR-UHFFFAOYSA-L 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229940124551 recombinant vaccine Drugs 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
METHOD FOR SURFACE DISPLAY OF PROTEINS ON GENETIC CARRIERS TECHNICAL FIELD The present invention relates to a method for surface display of proteins, in particular to methods for displaying a protein of interest on surface of spore, etc., for improving a protein of interest and for isolating a substance of interest. BACKGROUND ART The technology of surface display in which organism displays on its surface the desired proteinaceous substance such as peptide and polypeptide has wider application fields depending on the types of protein displayed or host organism (Georgiou et al., 1993, 1997; Fischetti et al., 1993; and Schreuder et al., 1996). Such conventional surface display technology has been developed by use of several unicellular organisms such as bacteriophage, bacteria, yeast and mammalian cell. The gene of protein to be displayed is contained in host organism and thus the host can be selectively screened using the characteristics of the protein displayed, thereby obtaining the desired gene from the selected host with easiness. Therefore, such surface display technology can guarantee a powerful tool on molecular evolution of protein (see WO 9849286; and U. S. Pat. No. 5,837,500). High-Throughput Screening For instance, phage displaying on its surface antibody having desired binding affinity is bound to immobilized antigen and then eluted, followed by propagating the eluted phage, thereby yielding the gene coding for target antibody from phage (U. S. Pat. No. 5,837,500). The bio panning method described above can provide a tool to select target antibody by surface displaying antibody library on phage surface in large amount and comprises the consecutive steps as follows: (1) constructing library; (2) surface displaying the library; (3) binding to immobilized antigen; (4) eluting the bound phage; finally (5) propagating selected clones. The technology of phage surface display has been found to be useful in obtaining the desired monoclonal variant form enormous library (e. g., 106-109 variants) and thus applied to the field of high-throughput screening of antibody. Antibody has been used in various fields such as therapy, diagnosis, analysis, etc. and thus its demand has been largely increased. In this context, there has been a need for novel antibody to have binding affinity to new substance or catalyze biochemical reaction. The hybridoma technology to produce monoclonal antibody has been conventionally used so as to satisfy the need. However, the conventional method needs high expenditure and long time for performance whereas the yield of antibody is very low. In addition to this, to screen novel antibody, more than 101 antibody libraries is generally used, as a result, the hybridoma technology has been thought to be inadequate in finding antibody exhibiting new binding property. Many researches has focused on novel methods which is easier and more effective that the bio panning method described above and then developed novel technologies performed in such a manner that libraries are displayed on surface of bacteria or yeast and then cells displaying target protein is sorted with flow cytometry in a high-throughput manner. According to the technology, antigen labeled with fluorescent dye is bound to surface-displaying cell and the antibody having the desired binding affinity is isolated with flow cytometry capable of analyzing more than 108 cells a hour. Francisco, et al., have demonstrated the usefulness of microbial display technology by revealing that surface-displayed monoclonal antibody could be concentrated with flow cytometry at rate of more than 105, finally more than 79% have been proved to be the desired cells (Daugherty et al., 1998). Live Vaccine The surface display technology mentioned above can display antigen or fragment thereof and hence provide a delivery system for recombinant live vaccine. Up to now, attenuated pathogens or viruses have been predominantly employed as vaccine. Particularly, the bacteria have been found to express antigen intracellularly or extracellularly or on its cell membrane, thereby delivering antigen to host cell. The surface-displayed live vaccine induces a potential immune reaction and expresses continuously antigen during propagation in host cell; therefore, it has been highlighted as novel delivery system for vaccine. In particular, pathogenderived antigenic epitope displayed on surface of nonpathogenic E. coli or Salmonella is administered orally in viable form and then exhibits to induce immune reaction in more continuous and powerful manner (Georgiou et al., 1997; and Lee et al., 2000). Whole Cell Bioconversion Whole cell as biocatalyst displaying on its surface enzyme capable of catalyzing chemical reaction can avoid necessities for direct expression, isolation and stabilization of enzyme. In case of expressing enzyme in cell for bioconversion, the cell is compelled to recovery and chemical (e. g., toluene) treatment to ensure impermeability of substrate. In addition, the lasting use renders the enzyme inactive or gives a problem on transference of substrate and product, thus dropping the productivity of overall process. The above-mentioned shortcomings can be removed using enzyme displayed on cell surface (Jung et al, 1998a: 1998b). With whole cell displaying on its surface phosphodiesterase, organophosphorous-typed parathion and paraoxon with higher toxicity can be degraded, which is a typical example representing the applicability of cells displaying enzyme to environmental purification process (Richins et al., 1997). Antipeptide Antibody Martineau et al. have reported a highly simple method for production of antipeptide antibody using surface display technology of E. coli (Martineau et al., 1991). As described, the desired peptide is displayed on the protruding region of MalE and outer membrane protein, LamB and then whole cell or fragmented cell is administered to animal so as to generate antipeptide antibody. The method makes it possible to produce antibody with avoiding chemical synthesis of peptide and its linkage to carrier protein. Whole Cell Absorber To immobilize antibody or polypeptide on suitable carrier, which is useful in absorption chromatography, several subsequent steps must be performed, for example, protein production by fermentation, isolation of protein in pure form, and immobilization on a carrier. Generally, it is difficult to prepare the bioabsorber. As absorber, a whole cell displaying absorption protein has been developed. The whole cell absorber known mostly is Staphylococcus aureus displaying on its surface protein A naturally, which has a high binding affinity to Fc domain of mammalian antibody. Currently, novel method has been proposed to remove and recover heavy metals, which employs metallothionein or metal-absorption protein displayed on microbial cell surface in large amount (Sousa et al., 1996,1998; and Samuelson et al., 2000). The method is more effective in removing and recovering heavy metals from contamination source in comparison with the conventional method using metal-absorption microbes. As understood based on the matters described above, in order to display foreign protein on cell surface, a suitable surface protein and foreign protein must be linked each other in gene level to express fusion protein, and the fusion protein should pass stably across inner membrane of cell to be attached to cell surface. Preferably, the surface protein having the following characteristics is recommended as surface display motif: 1) existence of secretory signal enabling passage across inner membrane of cell, 2) existence of target signal enabling stable attachment to cell surface, 3) high expression level on cell surface, and 4) stable expression regardless of protein size (Georgiou et al., 1993). Meanwhile, according to the existing surface display methods described above, the motif for surface display is required to genetically modified in order to incorporate a protein of interest to N-or C terminal, or central region of surface protein. All the proteins surface-displayed is expressed in a fusion form with surface display motif. Therefore, the resulting protein surface-displayed is a modified protein rather than wild type protein. Up to date, the developed surface display systems are as follows: phage surface display system (Chiswell and McCarferty, 1992), bacterial surface display system (Georgiou et al., 1993; Little et al., 1993; and Georgiou et al., 1997), surface display system of Gram negative bacteria (Francisco et al., 1992; Fuchs et al., 1991; Klauser et al., 1990,1992; and Hedegaard et al., 1989), surface display system of Gram positive bacteria (Samuelson et al., 1995; Palva et al., 1994; and Sleytr and Sara, 1997), and surface display system of yeast (Ferguson, 1988; and Schreuder et al., 1996). Furthermore, it has been developed that a protein of interest fused to spore coat protein is displayed on spore surface. For example, U. S. Pat. No. 5,766,914 discloses a method of producing and purifying enzymes using fusion protein between cotC or cotD among spore coat proteins of Bacillus subtilis and lacZ as reporter. U. S. Pat. Nos. 5,837,500 and 5,800,821 also indicate cotC and cotD as a preferable surface display motif, but its experimental demonstrations are not described. According to a surface display system of Gram negative bacteria, the incorporation of foreign polypeptide into surface structure results in not only its steric limitation which makes it impossible to have stable membrane protein (Charbit et al., J. Immunol, 139: 1644-1658 (1987); and Agterberg et al., Gene, 88: 37-45 (1990)) but also drop of the stability of cell outer membrane and its viability. E. coli as display host, which has been intensively studied, uses generally cell outer membrane protein as surface display motif. However, the over-expression of cell outer membrane protein fused to foreign protein is likely to bring about structural instability of cell outer membrane, consequently, diving the viability of host cell (Georgiou et al., 1996). The problems in the conventional display methods described above, is due to preparation of fusion protein between a protein of interest and surface display motif for display. Where the fusion protein is expressed in small amount, the reaction efficiency in whole cell bioconversion, protein array and antibody production is decreased; if overexpressed, it is very likely to lead to the shortcomings mentioned above. In addition, the surface display methods using the fusion protein are depended on the extent of incorporation of surface display motif into cell, spore or phage surface, giving rise to limitation of the amount of protein displayed. As described above, the conventional surface display technology is fundamentally dependent on formation of fusion protein between a protein of interest and surface display motif. Consequently, there occur several shortcomings in conventional surface display systems: (1) necessity of getting knowledge of a gene sequence of surface display motif; (2) necessity of cloning a gene of surface display motif; (3) being very likely to affect the tertiary structure of a protein of interest by surface display motif; (4) rendering a protein of interest inactive when a protein of interest is active only in multimeric form and a fusion protein is independently surface-displayed; (5) limitation of the amount of protein displayed since the surface display methods using the fusion protein are depended on the extent of incorporation of surface display motif into host cell surface; (6) inducing a structural instability of host cell surface when a protein of interest is surface displayed in excess, thereby dropping resistance to environment and viability of host cell. Consequently, for developing novel surface display system, which is capable of overcoming the shortcomings in conventional methods, the following characteristics should be accomplished: (1) being capable of constructing system without knowledge on a gene sequence of surface display motif; (2) being capable of constructing system without cloning a gene of surface display motif; (3) being capable of displaying a protein of interest on host cell surface after forming a inherent structure thereof; (4) being capable of increasing an amount of protein surfacedisplayed by means of nonselective linkages; and/or (6) not reducing a resistance to environment and a viability of host cell even when a protein of interest is surface displayed in excess. Throughout this application, various patents and publications are referenced and citations are provided in parentheses. The disclosure of these patents and publications in their entities are hereby incorporated by references into this application in order to more fully describe this invention and the state of the art to which this invention pertains. DISCLOSURE OF INVENTION Under such situation, the present inventors have made intensive studies to be from the shortcomings of the conventional surface display methods, and as a result, we have developed novel display system eliminating the need of motif for surface display. Surprisingly, it has been found that the developed system is capable of displaying any protein on surface with maintaining inherent structure thereof and when displaying in excess, a genetic carrier maintains its viability and resistance to surrounding environment. Accordingly, it is an object of this invention to provide a method for preparing a protein of interest surface-displayed on genetic carrier. It is another object of this invention to provide a method for improving a protein of interest by using the method for surface display on genetic carrier. It is still another object of this invention to provide a method for isolating a substance of interest in mixture by using the method for surface display on genetic carrier. It is further object of this invention to provide a method for bioconversion by using the method for surface display on genetic carrier. It is still further object of this invention to provide a method producing an antibody to antigen in vertebrates by using the method for surface display on genetic carrier. It is another object of this invention to provide a vector for displaying on surface of genetic carrier a protein of interest. It is still another object of this invention to provide a microbial transformant for displaying on surface of genetic carrier a protein of interest. It is further object of this invention to provide a complex between genetic carrier and protein of interest. It is still further object of this invention to provide a genetic carrier library diaplaying on its surface variants of a protein of interest It is another object of this invention to provide a protein microarray prepared by using the method for surface display on genetic carrier. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 schematically illustrates the principle of the present invention; Fig. 2 is a graph representing activity of lipase of Pseudomonas fluorescens which is displayed on spore surface ; Fig. 3 is a graph demonstrating spore-surface display of wild type lipase which is expressed in host cell; Fig. 4 is a graph showing the result of flow cytometry analysis for confirming spore-surface display of wild type carboxymethylcellulase; Fig. 5 is a genetic map of vector, pCrylp-CMCase-hp, for spore-surface display; Fig. 6 is a graph showing the result of flow cytometry analysis for confirming spore-surface display of carboxymethylcellulase with modified secretory signal; Fig. 7 is a genetic map of vector, pCrylp-CMCasehis, for spore-surface display; and Fig. 8 is a graph showing the result of flow cytometry analysis for confirming spore-surface display of carboxymethylcellulase with a fusion sequence, cationic domain. BEST MODE FOR CARRYING OUT THE INVENTION The term used firstly herein,"genetic carrier" refers to an organism displaying on its surface a protein of interest and having the following properties: (1) selected from the group consisting of spore and virus; (2) having capacity of forming noncovalent bond to a protein of interest with a desired dissociation constant, expressed in host cell harboring the genetic carrier; and (3) if necessary, its surface properties is able to be modified via genetic engineering method. The term used herein"host cell"has a different meaning from one disclosed and indicated in prior publications related to surface display of protein. The term used herein"host cell"refers to a cell expressing a protein of interest and having the following properties: (1) being capable of being transformed with a gene encoding a protein of interest; (2) being capable of harboring genetic carrier such as spore and virus and proliferating the genetic carrier; and (3) being capable of being manipulated genetically, if necessary. As described above, in the present specification, the terms,"genetic carrier"displaying on its surface a protein of interest and"host cell"expressing a protein of interest are employed with strictly different meanings. In one aspect of this invention, there is provided a method for preparing a protein of interest surfacedisplayed on genetic carrier, which comprises the steps of: (a) transforming a host cell harboring the genetic carrier selected from the group consisting of spore and virus with a vector containing a gene encoding the protein of interest; (b) culturing the transformed host cell and expressing the protein of interest in the host cell; and (c) allowing to form noncovalent bond between the expressed protein and a surface of the genetic carrier so that the protein of interest is displayed on the surface of the genetic carrier. In another aspect of this invention, there is provided a method for improving a protein of interest, which comprises the steps of: (a) constructing a gene library of the protein of interest by means of mutating the gene encoding the protein of interest; (b) preparing a vector library containing the constructed gene library; (c) transforming a host cell harboring a genetic carrier selected from the group consisting of spore and virus with the vector library; (d) culturing the transformed host cell and expressing the variants of the protein of interest in the host cell; (e) obtaining a genetic carrier library by means of allowing to form noncovalent bond between the expressed protein variant and a surface of the genetic carrier so that the variant is displayed on the surface of the genetic carrier; and (f) screening the genetic carrier displaying on its surface the variant of the protein of interest having a desired property. In still another aspect of this invention, there is provided a method for isolating a substance of interest in mixture, which comprises the steps of : (a) constructing a gene library encoding a variant of binding protein or binding domain thereof by means of mutating the gene encoding the binding protein or binding domain as protein of interest; (b) preparing a vector library containing the constructed gene library; (c) transforming a host cell harboring a genetic carrier selected from the group consisting of spore and virus with the vector library; (d) culturing the transformed host cell and expressing the variants of the binding protein or binding domain in the host cell; (e) obtaining a genetic carrier library by means of allowing to form noncovalent bond between the expressed binding protein variant or binding domain variant and a surface of the genetic carrier so that the variant is displayed on the surface of the genetic carrier; (f) contacting the genetic carrier library with a predetermined substance and screening an improved binding protein or binding domain thereof by means of selecting the genetic carrier displaying on its surface the variant binding the predetermined substance; (g) contacting the genetic carrier displaying on its surface the improved binding protein or binding domain thereof with the mixture to isolate the substance of interest in mixture. The present method has been developed based on a novel concept, which is largely different from the conventional surface display methods. The present method takes advantage of properties of constituents on surface of genetic carrier and, in particular, noncovalent bonds between a protein on surface of genetic carrier and a protein of interest. The principle strategy of this invention, using a spore as genetic carrier, is illustratively exemplified in Fig. 1. Referring to Fig. 1, a host cell is transformed with vector carrying a sequence encoding a protein of interest, the protein of interest is expressed intracellularly or extracellularly at or prior the period of forming spore and the surface display of protein of interest is finally accomplished by virtue of noncovalent bonds between the protein of interest and the surface of spores formed in host cell. As described above, the striking feature of the present invention lies in eliminating a need of a motif for surface display which is essential in conventional methods for surface display of protein. Because the instant method circumvents a necessity for a motif for surface display, the proteins found to be difficult to pass across cell membrane, when expressed in host cell, can be displayed well on surface of genetic carrier and when host cells are lysed to expose the genetic carrier, the genetic carriers displaying on its surface the proteins can be recovered. The recovered complex between protein of interest and genetic carrier has a wide application. According to the present methods, a spore or virus can be employed as genetic carrier. The spore is a preferable genetic carrier due to its properties as follows (Driks, 1999): (1) a higher heat stability; (2) a significant stability to radioactivity ; (3) a stability to toxins; (4) a higher stability to acid and base; (5) a significant stability to lysozyme; (6) a resistance to dryness; (7) a higher stability to organic solvents; (8) no metabolic activity; and (9) shorter time for obtaining spore, e. g. within several hours. According to the methods, when virus is used as genetic carrier, it is preferred to use bacteriophage, and the protein of interest expressed in prokaryotic host cell is surface-displayed via nonconvalent bond to coat proteins of the bacteriophage. Where the bacteriophage is located in periplasm of host cell, the signal peptide may be fused to the protein of interest to permit secretion toward periplasm, thereby ensuring a surface display. If the protein of interest cannot be naturally bound to coat proteins of bacteriophage, it may be fused to a motif capable of binding to coat proteins of bacteriophage in order to allow surface display. According to a preferred embodiment, the genetic carrier has a surface protein modified to enhance noncovalent bond with the protein of interest. The method for modification of the genetic carrier includes: (i) fusing oligopeptide or polypeptide, which enhance noncovalent bond between the protein of interest and genetic carrier, to the surface protein of genetic carrier; (ii) subjecting the surface protein of genetic carrier to site-directed mutagenesis; and (iii) subjecting the surface protein of genetic carrier to random mutagenesis, but not limited to. In the present methods, the protein of interest includes any protein and peptide, for example, hormone, hormone analogue, enzyme, enzyme inhibitor, signal transduction protein or fragment thereof, antibody or fragment thereof, single chain antibody, binding protein or fragment thereof, peptide, antigen, adhesive protein, structural protein, regulatory protein, toxin protein, cytokine, transcription regulatory protein, blood clotting protein and plant defense-inducing protein, but not limited to. The binding protein or binding domain thereof used in this invention, includes any protein or domain thereof capable of a predetermined substance, for example, antibody or antibody domain, when a certain antigenic substance is isolated. The binding protein or binding domain includes, but not limited to, protease inhibitor, crambin, enterotoxin, conotoxin, apaminm lysozyme, ribonuclease, charybdotoxin, cystatin, eglin, ovomucoid, azurin, tumor necrosis factor and CD4. According to the present methods, either monomer or multimer (including homo multimer and hetero multimer) can be surface-displayed. Multimeric protein has generally a complete activity only when all of its monomers are combined. In conventional methods, it has been found that multimeric protein is surfacedisplayed in inactive form because its monomers are independently surface-displayed each other. According to the present methods, the multimeric proteins can be displayed on surface of genetic carrier with maintaining its integral structure. According to a preferred embodiment, the protein of interest to be surface-displayed may be modified so as to enhance noncovalent bonds to genetic carrier. The modification methods include: (i) deleting a portion of amino acids of the protein of interest; (ii) fusing oligopeptide or polypeptide, which enhance noncovalent bond between the protein of interest and genetic carrier, to the protein of interest or deleted form of (i); (iii) subjecting the protein of interest to sitedirected mutagenesis; and (iv) subjecting the protein of interest to random mutagenesis, but not limited to. The method of deleting a portion of amino acids of the protein of interest may be performed in various manners, for example, by deleting ionic amino acids from N-terminal sequence (e. g. signal peptide) of the protein of interest. The protein of interest thus modified enhances hydrophobic interaction with genetic carrier and therefore, can be surface-displayed with lower dissociation constant. It has been reported that the spore surface carries anionic charge. Therefore, it is preferred that a cationic peptide is fused to the protein of interest for surface display. In the present methods, as a gene encoding protein of interest to be transformed, two or more repeated sequences are also useful. In two or more repeated sequences, the repeated sequences may be the same or different each other. Other combinations also may be useful in the fusion sequence. In addition, the gene used in transformation, may exist as plasmid in host cell independently or as integrated form into chromosome of host cell. The expression of protein of interest can be induced by virtue of its own promoter or other suitable promoters inducible in host cell. According to the present methods, noncovalent bonds, in particular, one or more among hydrophobic bond, ionic bond, hydrogen bond, and van der Waals bond, permits the interaction between protein of interest and genetic carrier. According to a preferred embodiment, the host cell harboring spore includes, but not limited to, a sporeforming Gram negative bacterium such as Myxococcus; a spore-forming Gram positive bacterium such as Clostridium, Paenibacillus and Bacillus ; a sporeforming Actionmycete ; a spore-forming yeast such as Saccharomyces cerevisiae, Candida and Hansenulla and a spore-forming fungus. More preferably, the host cell is the spore-forming Gram positive bacterium and the most preferably, Bacillus including Bacillus subtilis, Bacillus thuringiensis and Bacillus megaterium. In particular, Bacillus subtilis is advantageous in the senses that genetic knowledge and experimental methods on its spore forming as well as culturing method are well known. According to a preferred embodiment, the host cell is one mutated to eliminate a production of intracellular protease or extracellular protease which is involved in degradation of the surface-displayed protein of interest. Although the present methods is fundamentally directed to surface display via noncovalent bond between genetic carrier and protein of interest, additional covalent bond may be used, if necessary for more stabilized linkage. The stabilizing the bond between the surface of the genetic carrier and the protein of interest can be performed by means of forming covalent bonds to between the surface of the genetic carrier and the protein of interest by use of physical, chemical or biochemical methods following displaying the protein of interest on the surface of genetic carrier via noncovalent bond. Among the methods to form covalent bond, a treatment of glutaraldehyde (DeSantis G. and Jones J. B. Curr. Opin. Biotechnol. 10: 324-330 (1999)) is preferable as chemical method, a treatment of ultraviolet (Graham L., and Gallop P. M. Anal. Biochem. 217: 298-305 (1994)) is preferable as physical method and a treatment of enzyme ensuring formation of covalent bond (Gao Y., and Mehta K., J. Biochem. 129: 179-183 (2001)) as biochemical method. In the method for preparing a protein of interest surface-displayed on genetic carrier, it is preferred that the method further comprises the step of screening the genetic carrier displaying on its surface the protein of interest. In the method for improving a protein of interest, the step of constructing a gene library by mutation of wild type gene of protein of interest by means of: DNA shuffling method (Stemmer, Nature, 370: 389-391 (1994)), StEP method (Zhao, H., et al., Nat. Biotechnol., 16: 258-261 (1998)), RPR method (Shao, Z., et al., Nucleic acids Res., 26: 681-683 (1998)), molecular breeding method (Ness, J. E., et al., Nat. Biotechnol., 17: 893-896 (1999)), ITCHY method (Lutz S. and Benkovic S., Current Opinion in Biotechnology, 11: 319-324 (2000)), error prone PCR (Cadwell, R. C. and Joyce, G. F., PCR Methods Appl., 2: 28-33 (1992)) and point mutagenesis (Sambrook et al., Molecular Cloning : A Laboratory Manual, Cold Spring Harbor, N. Y., 1989). According to a preferred embodiment of method for improving a protein of interest, the genetic carrier is spore and the step of screening is performed in such a manner that the spore library is treated with one or more selected from the group consisting of organic solvent, heat, acid, base, oxidant, dryness, surfactant and protease and then spore displaying on its surface the variant of protein of interest resistant to the treatment is selected. According to another preferred embodiment of method for improving a protein of interest, the genetic carrier is spore and the step of screening is performed in such a manner that the spore library is primarily treated with one or more selected from the group consisting of organic solvent, heat, acid, base, oxidant, dryness and surfactant followed by secondary treatment with protease and then spore displaying on its surface the variant of protein of interest resistant to the protease is selected. In the present methods, the step of screening may be performed by means of: (i) an activity of the protein of interest displayed on surface of genetic carrier; (ii) a protein being capable of recognizing a substance labeling the protein of interest; (iii) a labeled ligand being capable of binding to the protein of interest; or (iv) an antibody being capable of binding to the protein of interest specifically, but not limited to. Preferably, flow cytometry is employed in the screening by means of a labeled ligand being capable of binding to the protein of interest or an antibody being capable of binding to the protein of interest specifically. For example, a primary antibody is bound to the protein of interest displayed on spore surface and then reacted with a secondary antibody labeled with fluorescent chemical to stain the spore, followed by observation with fluorescence microscope or analysis with flow cytometry. If the secondary antibody is labeled with gold, the observation with electron microscope is enabled. Screening by use of activity of protein of interest can be performed by measuring colorimetric reaction catalyzed by the protein. In the present methods for preparing a protein of interest surface-displayed and for improving a protein of interest, it is preferred that following proliferation of genetic carrier screened, the protein variants with desired properties or genes encoding them are recovered. According a preferred embodiment using spore as genetic carrier, the recovery of spore is performed in such a manner that the display of the protein of interest on the spore surface is maximized by controlling culture time, after which culturing is terminated and the spore is then recovered. Suitable culture time is varied depending upon the type of cell used, for example, in case of using Bacillus subtilis as host, the culture time of 16-25 hours is preferred. The recovery of spore may be carried out according to the conventional methods known to one skilled in the art, more preferably, renografin gradients methods (C. R. Harwood, et al.,"Molecular Biological Methods for Bacillus."John Wiley & Sons, New York, p. 416 (1990)). The method for improving protein provide in a highthroughput manner, from wild type, (1) enzymes catalyzing non-biological reaction (e. g., Diels-Alder condensation); (2) enzymes with non-natural steroselectivity or regioselectivity; (3) enzymes with activity in organic solvent or organic solvent-aqueous solution two-phase system; and (4) enzymes with activity in extreme conditions such as high temperature or pressure. In addition, to select a variant of antibody with enhanced binding affinity, it is general that pH is abruptly changed or the concentration of base is adjusted to elute the variant. In a method using phage or bacteria as carrier, such elution conditions are likely to decrease the viability of phage or bacteria in medium. However, the methods for improving protein using system of spore surface display overcome the drawback. In further aspect of this invention, there is provided a vector for displaying on surface of genetic carrier a protein of interest, which comprises a replication origin, an antibiotic-resistance gene, a restriction site, a gene encoding the protein of interest, wherein the protein of interest, when expressed in host cell, is capable of forming noncovalent bond to the surface of genetic carrier. According to a preferred embodiment, the gene encoding the protein of interest is one mutated to enhance noncovalent bond between the surface of genetic carrier and the protein of interest. The gene encoding the protein of interest is mutated to (i) delete a portion of amino acids of the protein of interest; (ii) fuse oligopeptide or polypeptide, which enhance noncovalent bond between the protein of interest and genetic carrier, to the protein of interest or deleted form of (i); (iii) subject the protein of interest to site-directed mutagenesis; or (iv) subject the protein of interest to random mutagenesis. In still further aspect of this invention, there is provided a microbial transformant, characterized in that the transformant is produced by transformation a host cell harboring spore or virus with the present vector. According to a preferred embodiment, the host cell is one mutated to eliminate a production of intracellular protease or extracellular protease which is involve in degradation of the surface-displayed protein of interest. In another aspect of this invention, there is provided a complex between genetic carrier and protein of interest, characterized in that the complex is prepared by displaying on the surface of the genetic carrier, according to the method of claim 1, hormone, hormone analogue, enzyme, enzyme inhibitor, signal transduction protein or fragment thereof, antibody or fragment thereof, single chain antibody, binding protein or fragment thereof, peptide, antigen, adhesive protein, structural protein, regulatory protein, toxin protein, cytokine, transcription regulatory protein, blood clotting protein or plant defense-inducing protein. According to a preferred embodiment, the protein of interest is one modified by virtue of: (i) deleting a portion of amino acids of the protein of interest; (ii) fusing oligopeptide or polypeptide, which enhance noncovalent bond between the protein of interest and genetic carrier, to the protein of interest or deleted form of (i); (iii) subjecting the protein of interest to site-directed mutagenesis; or (iv) subjecting the protein of interest to random mutagenesis. In addition, the present complex may have additional covalent bonds to stabilize the bond between the surface of the genetic carrier and the protein of interest, in which the covalent bonds are formed by use of physical, chemical or biochemical methods following displaying the protein of interest on the surface of genetic carrier via noncovalent bond. In the present complex, a spore is a preferable genetic carrier. Where a spore is used as genetic carrier, it is preferred that the spore is nonreproductive one obtained by means of one or more methods selected from the group consisting of genetic method (Popham D. L., et al., J. Bacteriol., 181: 6205-6209 (1999)), chemical method (Setlow T. R., et al., J. Appl. Microbiol., 89: 330-338 (2000)) and physical method (Munakata N, et al., Photochem. Photobiol., 54: 761-768 (1991)). The present complex using a spore only as display means of protein of interest can obviate the necessity for reproduction of spore. It is considerable that the organisms genetically engineered is likely to be regulated under laws and rules; hence non-reproductive spore is preferable. The genetic method for rendering spore non-reproductive may be carried out by deletion of gene involved in spore reproduction of host cell. For example, Bacillus subtilis lack of cwlD gene is preferably used in this invention. Furthermore, it is preferable that the spore is derived from a variant mutated to increase its agglutination property by one or more methods selected from the group consisting of physical method (Wienc K. M., et al., Appl. Environ. Microbiol., 56: 2600-2605 (1990)), chemical method and genetic method. The spore with increased agglutination property is conveniently separated from resulting product in bioconversion performed in industrial scale. In a preferred embodiment, the genetic carrier is a bacteriophage. In still another aspect of this invention, there is provided a genetic carrier library diaplaying on its surface variants of a protein of interest, prepared by a process comprising the steps of: (a) constructing a gene library of the protein of interest by means of mutating the gene encoding the protein of interest; (b) preparing a vector library containing the constructed gene library; (c) transforming a host cell harboring a genetic carrier selected from the group consisting of spore and virus with the vector library; (d) culturing the transformed host cell and expressing the variants of the protein of interest in the host cell; (e) obtaining a genetic carrier library by means of allowing to form noncovalent bond between the expressed protein variant and a surface of the genetic carrier so that the variant is displayed on the surface of the genetic carrier; and (f) screening the genetic carrier displaying on its surface the variant of the protein of interest having a desired property. According to a preferred embodiment, the genetic carrier is a spore or bacteriophage. In further aspect of this invention, there is provided a method for bioconversion using protein with activity for conversion reaction, characterized in that the method employs the present complex between genetic carrier and protein of interest. Any protein capable of catalyzing (bio) chemical reaction including enzyme and enzymatic antibody is useful in this bioconversion. Meanwhile, the bioconversion process using surfacedisplayed enzymes requires a physiochemical stability of surface displaying genetic carrier in extreme conditions because the process is usually executed in high temperature and/or organic solvent. In particular, a chemical synthesis valuable in current industry is mainly carried out in organic solvent and the synthesis of chiral compound or the resolution of racemic mixture is also performed in highly severe physiochemical conditions. Therefore, the surfacedisplayed enzyme as well as the organisms displaying enzyme is compelled to have stability in such extreme conditions. In this connection, it is demonstrated that the present method for bioconversion using spore or virus for surface display is largely advantageous. The chemical processes using surface-displayed enzymes have been proposed (Georgiou et al., 1993). However, the proposed processes have generally required immobilization of cell surface with crosslinking agent since the host displaying enzyme is very unstable during process (Freeman et al., 1996). The present bioconversion process can be free from the disadvantage mentioned above. Because the surfacedisplayed enzyme as well as the genetic carrier displaying enzyme is largely stable, the present method avoids the immobilization. The present bioconversion method can be also applied to any type of enzyme such as lipase, protease, cellulase, glycosyltransferase, oxidoreductase and aldolase. In addition, the present method is useful in single step or multi-step reaction and in aqueous or non-aqueous solution. The present bioconversion method employs genetic carrier as free or immobilized form and can be performed with other microbes or enzymes. In still further aspect of this invention, there is provided a method producing an antibody to antigen in vertebrates, characterized in that the method comprises administering to vertebrates a composition containing an immunologically effective amount of the present complex between genetic carrier and protein of interest. According to the method producing an antibody of this invention, a composition containing an immunologically effective amount of the complex, preferably, further comprises adjuvant such as incomplete and complete Freund's adjuvants. In the present method, the administration may be carried out by oral and intravenous, intraperitoneal, subcutaneous and intramuscular injections. Boosting within suitable period after the first administration is preferable to yield a sufficient amount of antibody. Similar to DNA microarray, a protein microarray provides means for analyzing expression or expression level of target protein in certain cell. In order to fabricate protein array, the suitable proteins to be arrayed must be obtained and then immobilized on solid surface. During analysis using protein array, washing step is necessarily performed to remove unbound proteins and various treatments such as high temperature, higher salt concentration and pH adjustment are executed; therefore, it is pivotal to guarantee proteinaceous substance with higher stability in such detrimental environment. In addition, the conventional process for preparing protein array needs tedious and repetitive works such as cloning genes of several thousands to tens of thousands of proteins and immobilizing of the proteins expressed. Therefore, there remains a need to improve simplicity and rapidity of the works. According to the method for preparing protein microarray of this invention, it is ensured that the works described-above cane be performed with much greater readiness. In the present method, the present complex or the genetic carrier library aforedescribed is immobilized onto the solid substrate. The present protein microarray is prepared by means of immobilization of genetic carrier, which displays on its surface a protein of interest, onto a solid substrate. In the method for preparing protein array, the conventional processes may be used (see WO 0061806, WO 0054046, US 5807754, EP 0818467, WO 9742507, US 5114674 and WO 9635953). The protein microarray manufactured by the present invention has a variety of applicable fields including diagnosis, analysis of gene expression, analysis of interaction between proteins, analysis of interaction between protein and ligand, study on metabolism, screening novel or improved enzymes, combinatorial biochemical synthesis and biosensor. The solid substrate suitable in the present method includes, but not limited to, glasses (e. g., functionalized glasses), Si, Ge, GaAs, GaP, SiO, SiN4, modified silicone nitrocellulose, polyvinylidene fluoride, polystylene, polytetrafluoroethylene, polycarbonate, nylon, fiber and combinations thereof. The genetic carrier optionally may be attached to the array substrate through linker molecules. It is preferred that the regions of the array surface not being spotted are blocked. The amount of genetic carrier applied to each spot (or address) depends on the type of array. Interaction between the protein displayed on genetic carrier attached to solid substrate and the sample applied can be detected based on their inherent characteristics (e. g., immunogenicity) or can be rendered detectable by being labeled with an independently detectable tag (e. g., fluorescent, luminescent or radioactive molecules, and epitopes). The data generated with protein array of this invention can be analyzed using known computerized systems such as"reader"and"scanner". As understood from the all descriptions in this application, the present surface display method using genetic carrier adapted to all the present methods has several advantages: (1) avoiding a need of a motif for surface display; (2) ensuring a protein of interest to have its intact activity in such a manner that the protein of interest forms its inherent structure following expression and then is displayed on surface; (3) increasing an amount of a protein of interest surface-displayed because the protein is displayed via noncovalent bonds, i. e., in non-selective manner; and (4) no or little effect on viability and resistance to surrounding environment of genetic carrier although an amount of the protein surface-displayed is increased. The following specific examples are intended to be illustrative of the invention and should not be construed as limiting the scope of the invention as defined by appended claims. EXAMPLES Example 1: Validation on Spore Surface Display of Pure Isolated Lipase It has remained to be verified that a cytoplasmic protein can be bound and displayed on the spore surface as previously reported coat protein or structural protein (morphogen). On the base of the hydrophobic property of spore surface (Wiencek, K. M. et al., Appl. Environ. Microbiol., 56: 2600-2605 (1990)), the present inventors hypothesized that proteins with hydrophobic domains e. g. lipase (Brockerhoff H., Chem. Phys. Lipids, 10: 215 (1973)) may be attached to and thus displayed on the spore surface via hydrophobic bond. The hypothesis was verified by measuring the enzymatic activity of lipase after attachment of lipase, which is purified from Pseudomonas fluorescens, on pure spore isolated from Bacillus subtilis. Firstly, Bacillus subtilis DB104 strain (Kawamura F. and Doi R. H., J. Bacteriol., 160: 442-444 (1984)) was cultured for 24 hr at a shaking incubator (37C, 250 rpm) in GYS medium ((NH4)2SO4 2 g/1, yeast extract 2 g/1, K2HP04 0.5 g/l, glucose 1 g/1, MgSO4# H2O 0.41 gel, CaCl2# 2H2O 0.08 g/l, MnSO4# 5H2O 0.07 g/1), and the only pure spores were isolated using renografin gradients method (C. R. Harwood, et al.,"Molecular Biological Methods for Bacillus."John Wiley & Sons, New York, p. 416 (1990)). The pure isolated spores were confirmed under a microscope (1000 x, ALPHAPHOT-2, Nikon). 2 mg of the pure isolated Bacillus spores and 94 Ag of the partially purified Pseudomonas lipases (Ahn, J. H. et al., J. Bacteriol., 181: 1847-1852 (1999)) were mixed into 200 1 of 50 mM Tris buffer (pH 8.0), reacted without disturbance for 12 hr at 4C and the spores were isolated from the buffer by centrifugation. Subsequently, the isolated spores were rinsed three times with 0.5 W of 50 mM Tris buffer (pH 8.0) and finally the lipase-attached spores were purified. To measure the lipase activity attached on spores, the lipase-attached spores were suspended into PBS buffer, added 10% olive oil, reacted for 48 hr, 0.2 Mg cupric acid was treated on supernatant, and the final OD was measured at 715 nm. The result of supernatant indicated the lipase activity released from lipase attached spores by olive oil (Fig. 2). In Fig. 2, the line (1) represents the lipase-attached spores and the line (2) is control without lipase attachment, and the horizontal line refers to the reacting time for lipase activity. These results indicate that the lipase can bind to spore surface only via absorption due to hydrophobic interaction. These results exemplifies that any protein with hydrophobicity can be displayed on spore, and it is understood for those skilled in the art that a protein with hydrophobicity can be displayed on spore surface when the protein is expressed in a cell or secreted out of a cell. Example 2: Display of Wild Type Lipase on Spore Surface The spore display of wild type lipases, which are expressed in host cells, is examined as follows: The plasmid pBS: lipA (Bell P. J. L. et al, Biotechnol. Lett., 21: 1003-1006 (1999)) was gifted by Dr. Bergquist in Australia. PCR was performed using primer lipl (SEQ ID No: 1) and primer lip2 (SEQ ID No: 2) with template of the pBS: lipA plasmid. Taq polymerase purchased from Boehringer Mannheim was used for total 35 cycles of PCR under condition of denaturation for 30 sec at 94 C, annealing for 30 sec at 55C and extension for 1 min at 72 C. Then, each amplified PCR products were restricted with BamHI and KpnI and cloned into pCrylP-CMCase plasmid at the same restriction sites after excision of pre-cloned carboxymethylcellulase gene, and the cloned plasmids were transformed into Bacillus subtilis DB104 by natural transformation method (C. R. Harwood, et al.,"Molecular Biological methods for Bacillus."John Wiley & Sons, New York, p. 416 (1990)). The lipase activity was measured in the pure isolated spores after isolation of the spores from transformed Bacillus strain in the same manner as Example 1 (Fig. 3). In Fig. 3, the line (1) represents the spores displayed with wild type lipases and the line (2) is result of control spores, and the horizontal line refers to reaction time for lipase activity. These results indicate that proteins with hydrophobicity can be displayed on spore surface using the spore display system of this invention. The lipases expressed in this Example contain their secretory signal peptides at N-terminus leading to extracellular secretion. The secreted enzymes can be attached on the surface of spore exposed to medium after sporulation. Furthermore, the non-secreted enzymes in spite of the presence of their secretory signal peptides (Bron S., J. Biotechnol., 64: 313 (1998)) also can be attached on the spore surface in the course of spore formation due to their hydrophobic property. In a result, it is apparent that a protein with hydrophobicity can be displayed on spore surface regardless of that the protein is intracellularly expressed or secreted extracellularly. Example 3: Display of Wild Type Carboxymethylcellulase on Spore Surface For display of carboxymethylcellulase on spore surface, the carboxymethylcellulase gene isolated from Bacillus subtilis BSE616 strain (Park S. H. et al., Agric. Biol. Chem., 55: 441-448 (1991)) was cloned under control of a promoter of crylAa toxin gene isolated from Bacillus thurigiensis strain. At first, the crylAa promoter was amplified by PCR using primer 1AP1 (SEQ ID No: 3) and primer 1AP2 (SEQ ID No; 4) in the same condition as Example 2 with template of DNA isolated by Kalman S. et al. method (Appl. Environ. Microbiol., 59: 1131-1137 (1993)) from Bacillus thurigiensis kurstaki HD1 strain purchased from BGSC (Bacillus Genetic Stock Center, Ohio, USA). The PCR product was cloned into pGemT-easy vector purchased from Promega Co. (USA), subsequently digested with SphI and SalI and cloned into pUC19 plasmid (GenBank X02514) at the same restriction sites. The pUC19 plasmid was cleaved again with HindIII and BamHI restriction enzymes and the resultant fragment was inserted into pCPaC3 (KCTC 0831BP) at the same restriction sites, thereby constructing pCrylP-CMCase. The pCrylP-CMCase is a shuttle vector replicable both in E. coli and Bacillus strain. The final constructed plasmid, pCrylP-CMCase, was transformed into Bacillus subtilis DB104 strain by natural transformation method. Other methods such as conjugation or transduction can be applied for introduction of the recombinant vectors into Bacillus strain. After then, the transformed Bacillus strain by pCrylP-CMCase was cultured for 24 hr at a shaking incubator (37C, 250 rpm) in GYS medium, and the only pure spores were isolated using renografin gradients method. The measurement of carboxymetylcellulase activity in the isolated spores was carried out as follows: At first, 100 of spore suspension in 0.1 M potassium phosphate (pH 6.0) at a density to be OD (600nm) =1.4, was mixed with 200 of 1% carboxymethylcellulose solution in 0. 1 M potassium phosphate (pH 6.0), and reacted for 40 min at 50C. Following reaction, 900 ut of DNS solution (20% potassium sodium tartarate, 1% NaOH, 0.05% NaHSO3, 0.2% phenol, 1% 3,5dinitrosalicyclic acid) was added to the reacted solution, heated for 5 min and chilled in cold water. Optical density of supernatant after centrifugation was measured at wavelength of 575 nm. The carboxymethylcellulase activity of enzymes displayed on spores surface was 1.96 mU compared to 0 mU in control. In another confirmation method, flow cytometry also showed the display of carboxymethylcellulase on the spore surface of Bacillus strain transformed with pCrylP-CMCase, when flow cytometry was performed by method of Kim et al. (Appl. Environ, Microbiol., 66: 788-793 (2000)) employing a carboxymethylcellulase specific antibodies (Kim et al., Appl. Environ, Microbiol., 66: 788-793 (2000)) and flow cytometer (FACSort, Becton Dickinson, USA) (Fig. 4). In Fig. 4, line 1 represents control spores, line 2 refers to spores of Bacillus strain transformed by pCrylP-CMCase, vertical line denotes the number of spores and horizontal line is the strength of fluorescence. As shown in Fig. 4, the peak is transferred to right part in the spores displaying carboxymethylcellulase compared to control, which indicates that much more antibodies specific to carboxymethylcellulase bind on the spore surface transformed with pCrylP-CMCase plasmid. In a result, carboxymethylcellulases are attached on the spore surface transformed with pCrylP- CMCase. The carboxymethylcellulases expressed in this Example contain their secretory signal peptide at Nterminus leading to extracellular secretion. Although the secreted enzymes is likely to be attach on the surface of spore exposed to medium after sporulation, the non-secreted enzymes in spite of the presence of their secretory signal peptides (Bron S., J. Biotechnol., 64: 3-13 (1998)) also can be attached on the spore due to hydrophobic property of signal peptide. Consequently, it is understood that any protein with secretory signal can be displayed on spore surface by means of the spore-surface display system of the present invention. Example 4: Spore Display of Carboxymethylcellulase with Modified Secretory Signal N-terminal secretory signal peptide generally comprises N-terminal 2-3 cationic amino acid residues followed by hydrophobic domain and the cationic amino acids allow for the secretion of protein by binding to anionic phospholipid of cell membrane (Tjalsma H., Microbiol. Mol. Biol. Rev., 64: 515-547 (2000)). Furthermore, the substitution of the cationic amino acids with neutral ones is known to result in decrease of secretion (Chen M. and Nagarajan V., J. Bacteriol., 176: 5796-5801 (1994)). On the base of the facts, the inventors hypothesized that the decrease of protein secretion may increase the intracellular proteins and lead to much higher display of the proteins on spore surface owing to N-terminal hydrophobic domain of the proteins. In an effort to prove the hypothesis, the below experiment was carried out. To clone the carboxymethylcellulase with secretory signal containing only hydrophobic domain without the cationic amino acid residues, DNA of Bacillus subtilis 168 strain (Nature, 390: 249-256 (1997)), gifted by Dr. F. Kunst of Pasteur Institute in France, was isolated by method of Kalman et al. Thereafter, PCR was performed using primer cmc-hp (SEQ No: 5) and another primer (SEQ No : 6) with template of the isolated DNA in a same condition as Example 2. Subsequently, the PCR product was digested with BamHI and SacI, and cloned into the pCrylP-CMCase after excision of CMCase gene. The pCrylP-CMCase-hp (Fig. 5) was transformed into Bacillus subtilis DB104 by natural transformation method. The resulting transformant was denoted as"Bacillus subtilis BSK209", deposited on December 2,2000 in International Depository Authority, the Korean Collection for Type Cultures (KCTC) and given accession number KCTC 0902BP. SEQ ID No: 7 refers to the DNA sequence of the CMCase deficient of cationic amino acids in signal peptides and SEQ ID No : 8 is amino acid sequence of the CMCase thereof. And then, the transformed Bacillus strain BSK209 was cultured in a shaking incubator (37C, 250 rpm) and pure spores were isolated by renografin gradients method. The carboxymethylcellulase activity of the isolated spores showed 4.74 mU compared to 0 mU of control under a same method as described in Example 3. This result is 2.4 times higher than that of wild type, and indicates that much more enzymes were displayed than wild type. Moreover, flow cytometry using carboxymethylcellulase specific antibodies in the same manner as Example 3, showed much more enzymes displayed on the spore surface of the Bacillus strain transformed with pCrylP-CMCase-hp (Fig. 6). In Fig. 6, line 1 refers to control spore and line 2 is the spore of transformed Bacillus strain with pCrylP-CMCase-hp plasmid. As shown in Fig. 6, the peak is transferred to further right part compared to wild type carboxymethylcellulase shown in Fig. 4, which indicates much more carboxymethylcellulases bind to the spore surface. In a result, carboxymethylcellulase with secretory signal containing the only hydrophobic domain without the cationic residues is favorite form for spore display. From these results, it is understood that deletion or neutralization of N-terminal cationic signal amino acids can be employed to gain further facility in spore display. Furthermore, it is apparent that fusion of hydrophobic domain of the signal peptides or other hydrophobic domain to protein of interest without its signal peptides can be used for spore display. In addition, it is also obvious that increase of hydrophobicity by selective or random mutagenesis of gene encoding surface protein of genetic carrier, or by fusion of other oligo-or polypeptides enhancing noncovalent linkage between carrier protein and protein of interest will enhance display of protein of interest on spore surface. Example 5: Spore Surface Display of Carboxymethylcellulase Using Ionic Domain Although spore surface of Bacillus is hydrophobic as shown in Example 1, there are also anionic ones (Nishihara T., et al., Microbiol. Immunol., 25 : 763771 (1981)). The present inventors hypothesized that a cationic protein of interest may be displayed by ionic bond and fusion of cationic motif into a protein of interest without cationic property will enable to display the protein of interest on spore surface. In an effort to verify the hypothesis, the below example was carried out. In order to fuse a cationic domain to carboxymethylcellulase, 6 histidine residues were fused to N-terminus of mature form of the enzyme using primer as below. At first, PCR was performed using primer cmc-his (SEQ ID NO : 9) and primer cmc-ter (SEQ ID NO : 10) with template of DNA of Bacillus subtilis 168 in a same condition as Example 2. Subsequently, the PCR product was restricted with BamHI and SacI and cloned into pCrylP-CMCase described in Example 3 instead of CMCase gene. The constructed pCrylP-CMCase-his (Fig. 7) plasmid was transformed into Bacillus subtilis DB104 by natural transformation method. SEQ ID NO : 11 refers to the gene sequence for CMCase fused with 6 histidine residues at its Nterminal region and SEQ No. 12 is amino acid sequence thereof. And then, the Bacillus strain transformed with pCrylP-CMCase-his was cultured in a shaking incubator (37C, 250 rpm) and pure spores were isolated by renografin gradients method. The carboxymethylcellulase activity of the isolated spores showed 1.90 mU compared to 0 mU of control under the same method as described in Example 3. And flow cytometry using carboxymethylcellulase-specific antibodies in a same manner as Example 3, showed enzymes displayed on the spore surface of the transformed Bacillus strain with pCrylP-CMCase-his (Fig. 8). In Fig. 8, line 1 refers to control spore and line 2 represents the spore of transformed Bacillus strain with pCrylP-CMCase-his plasmid. As shown in Fig. 8, the peak is transferred to further right part compared to control, which indicates much more antibodies specific for carboxymethylcellulase bind to the spore surface. These results indicate that carboxymethylcellulase containing N-terminus with additional cationic domain bind to the spore surface of Bacillus transformed with pCrylP-CMCase-his. Therefore, it is obvious that increase of cationic property by selective or random mutagenesis of gene or by fusion with cationic domain in any protein will enhance spore display. In addition, it is also apparent that the fusion of other ologo-or polypeptides enhancing noncovalent bond between surface protein of genetic carrier and protein of interest, or increase of anionic property by selective or random mutagenesis of gene encoding surface protein of genetic carrier will improve spore surface display of cationic protein of interest. Based on the results of the Example showing increase of surface display by fusion of additional sequence, it is conceivable that it is helpful for surface display to fuse binding partners such as antibody-antigen or ligand-receptor to protein of interest and surface protein of genetic carrier. Furthermore, it is understood that the protein of interest displayed will be more stabilized by the treatment of glutaraldehyde, UV or enzymes catalyzing formation of covalent bond, thereby forming additional covalent bond between surface protein of genetic carrier and protein of interest. Example 6: Display of Protein of Interest on Phage Surface On the facts and findings verified in the above examples, it becomes apparent that protein of interest capable of binding to coat proteins of phage can be displayed on phage surface. Such possibility was validated as follows : Moreover, it is very likely that a protein of interest incapable of binding to phage surface may be displayed on phage surface by fusing a motif capable of binding to coat protein. At first, the hydrophobic domains are fused to both coat protein of phage and protein of interes. In addition, signal peptides for secretion toward periplasm are also fused. When they are expressed in a host cell, the protein of interest secreted is displayed on phage surface by hydrophobic interaction with coat protein of phage locating in periplasm. A modification capable of displaying via other linkage other than hydrophobic interaction is apparent to those skilled in the art based on the findings in this Example. Example 7: Directed Evolution of Protein of Interest Using Method for Display on Genetic Carrier It is possible to carry out directed evolution of protein of interest using the display systems designed in the invention, in which surface display is enabled by interaction between protein of interest and surface of genetic carrier. At first, error prone PCR is performed with template of carboxymethylcellulase gene (Cadwell, R. C. and Joyce, G. F., PCR Methods Appl., 2: 28-33 (1992)). The PCR is performed using primers specific for carboxymethylcellulase gene with template of pCPaC3 plasmid described in Example 3. PCR mixture is prepared by mixing 0.3 liM of each primers, 5 ng of DNA template, PCR solution (lOmM Tris (pH 8.3), 50 mM KCl, 7 mM MgCl2, 0.01% (w/v) gelatin), 0.2 mM dGTP, 0.2 mM dATP, 1 mM dTTP, 1 mM dCTP, 0.15 mM MnCl2, 5 U Taq polymerase from Bioneer (Korea) and DW up to 100. Total 13 cycles of PCR are performed under condition of denaturation for 30 sec at 94C, annealing for 30 sec at 50C and extension for 1 min at 72 C. Subsequently, the above PCR-amplified inserts are cloned into the replicable vectors and Bacillus subtilis DB104 is transformed with the cloned vectors by natural transformation. And then, carboxymethylcellulas are displayed on spore surface by culturing the transformed Bacillus strain in a shaking incubator for 24 hr and pure spores are isolated by renografin gradients method. Thereafter, the spores with modified carboxymethylcellulase are selected using the change of carboxymethylcelluase activity or flow cytometry with antibody specific for carboxymethylcellulase as described in Example 3. Example 8: Bioconversion Using Genetic Carrier Surface-Displaying Protein of Interest The bioconversion using lipase in organic solvent has been reported (Zaks, A. et al., Proc. Natl. Acad. Sci. USA. 82: 3192 (1985); and Klibanow, A. M., CHEMTECH, 16: 354 (1986)). It is indispensable to carry out reaction without inactivation of enzymes. To accomplish this purpose, fixation of lipases has been conventionally used (Mustranta, A. Forssell et al., Enz. Microb. Technol., 15 : 133 (1993); and Reetz, M. T. et al., J. Biotechnol. Biogen., 49: 527 (1996)). According to these reports, fixed lipases maintain high stability in organic solvent and increase synthesis compared to free lipases. To begin with, lipases are displayed on surface of spore according to the present invention and bioconversion is performed as described method (Zaks, A. et al., Proc. Natl. Acad. Sci. USA. 82: 3192 (1985); Klibanow, A. M., CHEMTECH, 16; 354 (1986)). The bioconversion according to the present invention can be also performed by displaying protein of interest on the surface of virus resistant to organic solvent. Example 9: Protein Array Using Genetic Carrier Surface-Displaying on Protein of Interest 10 spores displaying monoclonal antibodies against specific surface antigen are attached onto glass substrate for protein array (BMS, Germany) with aldehyde functional group on its surface using automated array apparatus. The attachment is made in a form of covalent linkage, which is Schiff base between amino group of protein on spore surface and aldehyde group on surface of slide glass. Although the displayed proteins attached on solid surface may be inactivated, they may have orientation. The protein array kit manufactured according to the present invention has a variety of applicable fields including diagnosis, analysis of gene expression, analysis of interaction between proteins, analysis of interaction between protein and ligand, study on metabolism, screening novel or improved enzymes, combinatorial biochemical synthesis and biosensor. Example 10: Production of Antibody Genetic Carrier Surface-Displaying on Protein of Interest Antibodies can be induced by displaying antigen capable to induce immune response in vivo. Firstly, pCrylP-CMCase containing carboxymethylcellulase as antigen used in Example 3 is transformed into Bacillus subtilis DB104 by natural transformation method. And then, the carboxymethylcellulases are displayed on spore surface by culture the transformed Bacillus strain in a shaking incubator supplemented with GYS media for 24 hr, and subsequently pure spores are isolated by renografin gradients method. The antigen-displayed spores are resuspended into PBS, and same volume of adjuvant is added. Thereafter, the above solution is mixed by vortex and injected i. v. into BALB/c mouse with age of 6-8 wk after birth. After 4 wk, second injection is carried out. Antibodies are induced by additional 2-3 time boostings. Example 11: Isolation of Specific Substance Using Genetic Carrier Surface-Displaying on Protein of Interest It is possible to isolate specific substance from mixture using genetic carrier displaying binding domain. Firstly, error prone PCR is performed with template of gene encoding binding domain (Cadwell, R. C. and Joyce, G. F., PCR Methods Appl., 2: 28-33 (1992)). The PCR is performed using primers specific for gene of interest with template of plasmid containing gene of interest or chromosome. PCR mixture is prepared by mixing 0.3 uM of each primers, 5 ng of DNA template, PCR solution (lOmM Tris (pH 8.3), 50 mM KCl, 7 mM MgCl2, 0.01% (w/v) gelatin), 0.2 mM dGTP, 0.2 mM dATP, 1 mM dTTP, 1 mM dCTP, 0.15 mM MnCl2, 5 U Taq polymerase from Bioneer (Korea) and DW up to 100. Total 13 cycles of PCR are performed under condition of denaturation for 30 sec at 94C, annealing for 30 sec at 50C and extension for 1 min at 72 C. Subsequently, the above PCR-amplified inserts are cloned into the replicable vectors to construct library in host cells. The host cells are transformed with the cloned vector library, the binding domain is expressed in host cells and displayed on the surface of genetic carrier, and the carrier displaying modified binding domain with aimed property is screened. The screened genetic carrier is isolated, proliferated, expressed and used to isolate specific substance by mixing with the mixture. As described in above, the present method for preparing protein of interest surface-displayed on genetic carrier can be applied to display various proteins on surface of genetic carrier in the absence of display motif, the full activity of protein of interest can be acquired owing to display after formation of its inherent structure, and the increase in an amount of protein of interest expressed and displayed never decreases a resistance against environment a viability of genetic carrier. REFERENCES 1. Agterberg, M., Adriaanse, H. and Tommassen, J. Use of the outer membrane protein PhoE as a carrier for the transport of a foreign antigenic determinant to the cell surface of Escherichia coli K-12. Gene 59: 145-150 (1987) 2. Agterberg, M., Adriaanse, H., van Bruggen, A., Karperien, M. and Tommassen, J. Outer membrane PhoE protein of Escherichia coli K-12 as an exposure vector : possibilities and limitations. Gene 88: 3745 (1990) 3. Arnold, F. H. and Volkov, A. A. Directed evolution of biocatalysis. Curr. Opin. Chem. Biol. 3: 54-59 (1999). 4. Charbit, A., Molla, A., Saurin, W. and Hofnung, M. Versatility of a vector for expressing foreign polypeptides at the surface of Gram-negative bacteria. Gene 70: 181-189 (1988) 5. Charbit, A., Sobczak, E., Michel, M.-L., Molla, A., Tiollais, P. and Hofnung, M. Presentation of two epitopes of the preS2 region of hepatitis B virus on live recombinant bacteria. J. Immunol 139: 16441658 (1987) 6. Chiswell, D. J. and McCafferty, J. Phage antibodies: will new'coliclonal'antibodies replace monoclonal antibodies. TIBTECH 10: 80-84 (1992) 7. Daugherty, P. S., Chen G., Olsen, M. J., Iverson, b. L., Georgiou, G. Antibody affinity maturation using bacterial surface display. Protein Eng. 11: 825-832 (1998) 8. d'Enfert, C., Ryter, A. and Pugsley, A. P. Cloning and expression in Escherichia coli of the Klebsiella pneumoniae genes for the production, cell surface localisation and secretion of the lipoprotein pullulanse. EMBO J. 6: 3531-3538 (1987) 9. Driks, A. Bacillus subtilis spore coat. Microbiol. Mol. Biol. Rev. 63 (1) : 1-20 (1999) 10. Ferguson, M. A. J. and Williams, A. F. Cell-surface anchoring of proteins via glycosylphosphatidylinositol structures. Ann. Rev. Biochem. 57: 285-320 (1988) 11. Fischetti, V. A., Medaglini, D., Oggioni, M. and Pozzi, G. Expression of foreign proteins on Grampositive commensal bacteria for mucosal vaccine delivery. Curr. Opin. Biotechnol. 4: 603-610 (1993) 12. Francisco, J. A., Earhart, C. F. and Georgiou, G. Transport and anchoring of b-lactamase to the external surface of Eshcherichia coli. Proc. Natl. Acad. Sci. USA 89: 2713-2717 (1992) 13. Freeman, A., Abramov, S., and Georgiou G. Siteprotected fixation and immobilization of Escherichia coli cells displaying surface-anchored beta-lactamase. Biotechnol. Bioeng. 62 (2) : 155-159 (1999). 14. Fuchs, P., Breitling, F., Dubel, S., Seehaus, T. and Little, M. Targeting recombinant antibodies to the surface of Escherichia coli : fusion to a peptidoglycan associated lipoprotein. Bio/Technology 9: 1369-1372 (1991) 15. Georgiou, G. Analysis of large libraries of protein mutants using flow cytometry. Adv. Protein Chem. 55: 293-315 (2000). 16. Georgiou, G., Poetschke, H. L., Stathopoulos, C. and Francisco, J. A. Practical applications of engineering Gram-negative bacterial cell surfaces. TIBTECH 11: 6-10 (1993) 17. Georgiou, G., Stathopoulos, C., Daugherty, P. S., Nayak, A. R., Iverson, B. L. and Curtiss III, R. Display of heterologous proteins on the surface of microorganisms: From the screening of combinatorial libraries to live recombinant vaccines. Nature Biotechnology 15: 29-34 (1997) 18. Georgiou, G., Stephens D., Stathopoulos, C., Poetschke H. L., Mendenhall J. and Earhart C. F. Display of b-lactamase on the Escherichia coli surface: outer membrane phenotypes conferred by Lpp'-OmpA'-b- lactamase fusions. Protein Eng. 9: 239-247 (1996) 19. Hedegaard, L. and Klemm, P. Type 1 fimbriae of Escherichia coli as carriers of heterologous antigenic sequences. Gene 85: 115-124 (1989) 20. Jung, H. C., Lebeault, J. M. and Pan, J. G. Surface display of Zymomonas mobilis levansucrase by using the ice-nucleation protein of Pseudomonas syringe. Nature Biotechnol. 16: 576-580 (1998a). 21. Jung, H. C., Park, J. H., Park, S. H., Lebeault, J. M. and Pan, J. G. Expression of carboxymethylcellulase on the surface of Escherichia coli using Pseudomonas syringe ice-nucleation protein. Enzyme Microb. Technol. 16: 576-580 (1998b). 22. Kim, E. J. and Yoo, S. K. Cell surface display of CD8 ecto domain on Escherichia coli using ice nucleation protein. Biotechnol. Tech. 12: 197-201 (1998). 23. Kim, E. J. and Yoo, S. K. Cell surface display of hepatitis B virus surface antigen on Escherichia coli using Pseudomonas syringe ice-nucleation protein. Lett. Appl. Microbiol. 29: 292-297 (1999). 24. Kim, Y. S., Jung, H. C. and Pan, J. G. Bacterial cell surface display of an enzyme library for selective screening of improved cellulase variants. Appl. Environ. Microbiol. 66: 788-793 (2000). 25. Kwak, Y. D., Kim, E. J. and Yoo, S. K. Cell surface display of human immunodeficiency virus type I gpl20 on Escherichia coli by using ice-nucleation protein. Clinic. Diag. Lab. Immun. 6: 499-503 (1999). 26. Klauser, T., Kramer, J., Otzelberger, K., Pohlner, J. and Meyer, T. F. Characterization of the Neisseria Iga-core: The Essential unit for outer membrane targeting and extracellular protein secretion. J. Mol. Biol. 234: 579-593 (1993) 27. Klauser, T., Pohlner, J. and Meyer, T. F. Extracellular transport of cholera toxin B subunit using Neisseria IgA protease-domain: conformationdependent outer membrane translocation. EMBO J. 9: 1991-1999 (1990) 28. Kornacker, M. G. and Pugsley, A. P. The normally periplasmic enzyme-lactamase is specifically and efficiently trnaslocated through the Escherichia coli outer membrane when it is fused to the cell-surface enzyme pullulase. Mol. Microbiol. 4 (7): 1101-1109 (1990) 29. Lee, J. S., Shin, K. S., Pan, J. G. and Kim, C. J. Nature Biotechnol. 18: 645-648 (2000) 30. Lewis P. J. and Errington J. Use of green fluorescent protein for detection of cell specific gene expression and subcellular protein localization during sporulation in Bacillus subtilis. Microbiology 142: 733-740 (1996) 31. Little, M., Fuchs, P., Breitling, F. and Dubel, S. Bacterial surface presentation of proteins and peptides: an alternative to phage display technology, TIBTECH 11: 3-5 (1993) 32. Martineau, P., Charbit, A., Leclerc, C., Werts, C., O'Callaghan, D. and Hofnung, M. A genetic system to elicit and monitor antipeptide antibodies without peptide synthesis. Bio/Technology 9: 170-172 (1991) 33. Newton, S. M., Jacob, C. O. and Stocker, B. A. D. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 244: 70-72 (1989) 34. Ochs, M., Angerer, A., Enz, S. and Braun, V. Surface signaling in transcriptional regulation of the ferric citrate transport system of Escherichia coli : mutational analysis of the alternative sigma factor Feel supports its essential role in fec transport gene transcription. Mol. Gen. Genet. 250: 455-465 (1996) 35. Palva, A. M. and Palva, I. A. Lactobacillus expression system using surface protein gene sequences, W094/00581 (1994). 36. Richins, R. D., Kaneva, I., Mulchandani, A., and Chen, W. Biodegradation of organophosphorus pesticides by surface-displayed organophosphorus hydrolase. Nature Biotechnol. 15: 984-987 (1997). 37. Samuelson, P., Hansson, M., Ahlborg, N., Androoni, C., Gotz, F., Bachi, T., Nguyen, T. N., Binz, H., Ulhen, M. and Stahl, S. Cell surface display of recombinant proteins on Stapholococcus carnosus. J. Bacteriol. 177 (6): 1470-1476 (1995). 38. Samuelson, P., Wernerus, H., Svedberg, M. and Stahl S. Staphylococcal surface display of metalbinding polyhistidyl peptides. Appl. Envir. Microbiol. 66: 1243-1248 (2000). 39. Schreuder, M. P., Mooren, A. T. A., Toschka, H. Y., Theo Verrips, C. and Klis, F. M. Immobilizing on the surface of yeast cells. TIBTECH 14: 115-120 (1996). 40. Schulz, G. E. Bacterial porins: structure and function. Curr. Opin. Cell Biol. 5: 701-707 (1993) 41. Sleytr, U. B. and Sara, M. Bacterial and archaeal S-layer protein: structure-function relationships and their biotechnological applications. TIBTECH 15: 1-9 (1997) 42. Stathopoulos, C., Georgiou G., and Earhart C. F. Characterization of Escherichia coli expressing an Lpp'OmpA (46-159)-PhoA fusion protein localized in the outer membrane. Appl. Microbiol. Biotechnol. 45 (12): 112-119 (1996). 43. Sousa, C., Cebolla, A., and de Lorenzo, V. Enhanced metalloadsorption of bacterial cells displaying poly-His peptides. Nature Biotechnol. 14: 1017-1020 (1996). 44. Sousa, C., Kotrba, P., Ruml, T. Cebolla, A., and de Lorenzo, V. Metalloadsorption by Escherichia coli displaying yeast and mammalian metallothioneins anchored to the outer membrane protein LamB.. Bacteriol. 180: 2280-2284 (1998). 45. Taylor, I. M., Harrison, J. L., Timmis, K. N. and O'Conor, C. D. The TraT lipoprotein as a vehicule for the transport of foreign antigenic determinants to the cell surface of Escherichia coli K12 : structurefunction relationships in the TraT protein. Mol. Microbiol. 4 (8): 1259-1268 (1990) 46. Webb, C. D., Decatur A., Teleman A. and Losick R. Use of green fluorescent protein for ivsualization of cell specific gene expression and subcellular protein localization during sporulation in Bacillus subtilis J. Bacteriol. 177: 5906-5911 (1995) 47. Zheng L and Losick R., Cascade regulation of spore coat gene expression in Bacillus subtilis J. Mol. Biol. 212: 645-660 (1990) B@OAPEST TREATY ON THE INTERNATIONAL, RECO@NITION OF THE DEPOSIT OF MICROCRGANISM@ FO@@ THE P@RPOSE O@ : PATUNT PROCEDURE INTERNATIONAL FORM RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT issued pur : uant to Rule 7.1 TO: PAN, Jae-Gu #380-43, Doryong-dong, Yusong-ku, Jaejon 305-340, Repubiic of Korea EMI68.1 <tb> , <SEP> I. <SEP> IDENTIFICATION <SEP> OF <SEP> THE <SEP> MICROORGANISM] <tb> <SEP> Idericification <SEP> reference <SEP> Riven <SEP> by <SEP> the <SEP> Accession <SEP> number <SEP> given <SEP> by <SEP> t. <SEP> c <tb> <SEP> tEPUSfTUR <SEP> :, <SEP> IiTCR. <SEP> VATIONAL <SEP> DFPOSI'1' <SEP> : <SEP> IItY <tb> <SEP> ALTHOItI'rY <SEP> : <tb> <SEP> D'acillus <SEP> subtilis <SEP> BSK209 <tb> <SEP> . <SEP> i. <SEP> ¯. <SEP> ¯ <tb> <SEP> ! <SEP> B. <SEP> ClENTH-'IC <SEP> nESCRIPTION <SEP> AND/OR <SEP> PROPOSED <SEP> TAXONOMIC <SEP> UESIGNA'nO\j <tb> <SEP> The <SEP> microorganism <SEP> idendfied <SEP> under <SEP> I <SEP> above <SEP> was <SEP> accompanied <SEP> by <SEP> : <tb> <SEP> L <SEP> x <SEP> I <SEP> a <SEP> sc <SEP> ; <SEP> cntiic <SEP> description <tb> ! <SEP> [ <SEP> [a <SEP> proposed <SEP> Mxonomic <SEP> designation <tb> -with- <SEP> cross <SEP> where <SEP> applicable). <tb> <SEP> B. <SEP> HECEn <SEP> AND <SEP> ACCEPTANCE. <tb> <SEP> Thos <SEP> Internacional <SEP> Deposicar <SEP> Authority <SEP> accepts <SEP> the <SEP> microorganism <SEP> identified <SEP> under <SEP> I <SEP> above, <tb> ,. <SEP> vhich <SEP> was <SEP> received <SEP> by <SEP> it <SEP> on <SEP> December <SEP> 02 <SEP> 2000. <tb> L <SEP> N <SEP> ELFr <SEP> ot <SEP> [tEQUEST <SEP> FOR <SEP> COSF. <SEP> RSION <tb> <SEP> The <SEP> microorganism <SEP> identified <SEP> under <SEP> I <SEP> above <SEP> was <SEP> received <SEP> by <SEP> this <SEP> International <SEP> Depositary <tb> <SEP> Authority <SEP> on <SEP> and <SEP> a <SEP> request <SEP> to <SEP> convert <SEP> the <SEP> original <SEP> deposit <SEP> to <SEP> a <SEP> deposit <tb> <SEP> under <SEP> the <SEP> Budapest <SEP> Treaty <SEP> was <SEP> received <SEP> by <SEP> : <SEP> t <SEP> on <tb> <SEP> L <SEP> TER. <SEP> NATION\L <SEP> DErOSITARY <SEP> AU^l'L. <SEP> Oltl <SEP> IY <SEP> ¯¯ <tb> <SEP> Name <SEP> : <SEP> Korean <SEP> Collection <SEP> for <SEP> Type <SEP> Cultures <SEP> Signature <SEP> (s) <SEP> of <SEP> person <SEP> (s) <SEP> having <SEP> the <SEP> power <tb> <SEP> to <SEP> represent <SEP> the <SEP> Internadona. <SEP> t <SEP> nepositary <tb> <SEP> Authority <SEP> of <SEP> authorized <SEP> officials) <SEP> : <tb> <SEP> : <SEP> address <SEP> : <SEP> Korea <SEP> Research <SEP> Institute <SEP> of <tb> <SEP> Bioscicnce <SEP> and <SEP> Biotechnology <tb> <SEP> (ItItIBLi) <tb> <SEP> . <SEP> 52, <SEP> 0un-dong*Yusong-ku, <SEP> .' <tb> <SEP> Tacjon <SEP> 3C5-333. <SEP> RAE. <SEP> KyunK <SEP> Sook. <SEP> nirector, <tb> Republic <SEP> of <SEP> Korea <SEP> Date <SEP> : <SEP> December <SEP> 07 <SEP> 2000 <tb> . <tb>
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002556629A JP4128871B2 (en) | 2001-01-15 | 2002-01-15 | Gene carrier surface display method {MethodforSurfaceDisplayProteinsonGeneticCarriers} |
US10/466,208 US20040180348A1 (en) | 2001-01-15 | 2002-01-15 | Method for surface display of proteins of genetic carriers |
EP02716462A EP1353956A1 (en) | 2001-01-15 | 2002-01-15 | Method for surface display of proteins on genetic carriers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR2001/02156 | 2001-01-15 | ||
KR1020010002156A KR100810527B1 (en) | 2001-01-15 | 2001-01-15 | Method for Surface Display of Proteins on Genetic Carriers |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002055561A1 true WO2002055561A1 (en) | 2002-07-18 |
Family
ID=19704634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2002/000059 WO2002055561A1 (en) | 2001-01-15 | 2002-01-15 | Method for surface display of proteins on genetic carriers |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040180348A1 (en) |
EP (1) | EP1353956A1 (en) |
JP (1) | JP4128871B2 (en) |
KR (1) | KR100810527B1 (en) |
CN (1) | CN1264860C (en) |
WO (1) | WO2002055561A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007078127A1 (en) * | 2006-01-02 | 2007-07-12 | Korea Advanced Institute Of Science And Technology | Method for cell surface displaying of target proteins using bacillus anthracis exosporium |
US7608270B2 (en) | 2003-06-27 | 2009-10-27 | University Of Hull | Dosage form |
US7846654B2 (en) | 2005-07-28 | 2010-12-07 | University Of Hull | Uses of sporopollenin |
US8828464B2 (en) | 2008-07-09 | 2014-09-09 | University Of Hull | Whitened exine shells |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696251B1 (en) * | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
US6759243B2 (en) * | 1998-01-20 | 2004-07-06 | Board Of Trustees Of The University Of Illinois | High affinity TCR proteins and methods |
KR20020045400A (en) * | 2000-12-08 | 2002-06-19 | 반재구 | Method for Expression of Proteins on Spore Surface |
WO2006073514A2 (en) * | 2004-08-25 | 2006-07-13 | Tufts University | Compositions, methods and kits for repressing virulence in gram positive bacteria |
CN101622347A (en) * | 2007-01-12 | 2010-01-06 | 航道生物技术有限责任公司 | Combinatorial libraries of conformationally constrained polypeptide sequences |
EP2509997B1 (en) | 2009-12-07 | 2017-08-30 | i2 Pharmaceuticals, Inc. | Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties |
US8759044B2 (en) | 2011-03-23 | 2014-06-24 | Butamax Advanced Biofuels Llc | In situ expression of lipase for enzymatic production of alcohol esters during fermentation |
US8765425B2 (en) | 2011-03-23 | 2014-07-01 | Butamax Advanced Biofuels Llc | In situ expression of lipase for enzymatic production of alcohol esters during fermentation |
CN106046173B (en) * | 2016-06-07 | 2019-05-10 | 江南大学 | A kind of method that N-terminal fusion poly hexapeptide improves pig lysozyme antibiotic performance |
CN105861468B (en) * | 2016-06-07 | 2019-12-06 | 江南大学 | Method for improving antibacterial performance of pig lysozyme by fusing HLH functional domain at N end |
AU2018369878A1 (en) | 2017-11-16 | 2020-05-21 | Ginkgo Bioworks, Inc. | Paenibacillus-based endospore display platform, products and methods |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5096815A (en) * | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
US5766914A (en) * | 1995-01-26 | 1998-06-16 | Michigan State University | Method of producing and purifying enzymes |
US5800821A (en) * | 1995-03-10 | 1998-09-01 | New England Medical Center Hospitals, Inc. | Bacterial spores as a heat stable vaccine delivery system |
FR2740472B1 (en) * | 1995-10-27 | 1998-01-16 | Pasteur Institut | NOVEL STRAINS OF BACILLUS THURINGIENSIS AND PESTICIDE COMPOSITION CONTAINING THEM |
CA2297070A1 (en) | 1997-08-01 | 1999-02-11 | Morphosys Ag | Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex |
-
2001
- 2001-01-15 KR KR1020010002156A patent/KR100810527B1/en active IP Right Grant
-
2002
- 2002-01-15 CN CNB028037529A patent/CN1264860C/en not_active Expired - Fee Related
- 2002-01-15 US US10/466,208 patent/US20040180348A1/en not_active Abandoned
- 2002-01-15 WO PCT/KR2002/000059 patent/WO2002055561A1/en not_active Application Discontinuation
- 2002-01-15 EP EP02716462A patent/EP1353956A1/en not_active Ceased
- 2002-01-15 JP JP2002556629A patent/JP4128871B2/en not_active Expired - Fee Related
Non-Patent Citations (5)
Title |
---|
BENDAHMANE ET AL.: "Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions", J. MOLECULAR BIOLOGY, vol. 290, no. 1, 1999, pages 9 - 20, XP004462021, DOI: doi:10.1006/jmbi.1999.2860 * |
BODER ET AL.: "Yeast surface display for screening combinatorial polypeptide libraries", NATURE BIOTECHNOLOGY, vol. 15, no. 6, 1997, pages 553 - 557, XP002945515, DOI: doi:10.1038/nbt0697-553 * |
DE BERARDINIS ET AL.: "Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses", NATURE BIOTECHNOLOGY, vol. 18, no. 8, 2000, pages 873 - 876, XP002161760, DOI: doi:10.1038/78490 * |
LILJEQVIST ET AL.: "Surface display of the cholera toxin B subunit on staphylococcus xylosus and staphylococcus carnosus", APPL. ENVIRON. MICROBIOL., vol. 63, no. 7, 1997, pages 2481 - 2488, XP002433482 * |
VISPO ET AL.: "Displaying human interleukin-2 on the surface of bacteriophage", IMMUNOTECHNOLOGY, vol. 3, 1997, pages 185 - 193, XP000879612, DOI: doi:10.1016/S1380-2933(97)00012-2 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7608270B2 (en) | 2003-06-27 | 2009-10-27 | University Of Hull | Dosage form |
US7846654B2 (en) | 2005-07-28 | 2010-12-07 | University Of Hull | Uses of sporopollenin |
US8784851B2 (en) | 2005-07-28 | 2014-07-22 | University Of Hull | Topical formulations containing sporopollenin |
WO2007078127A1 (en) * | 2006-01-02 | 2007-07-12 | Korea Advanced Institute Of Science And Technology | Method for cell surface displaying of target proteins using bacillus anthracis exosporium |
US8883692B2 (en) | 2006-01-02 | 2014-11-11 | Korea Advanced Institute Of Science And Technology | Method for cell surface displaying of target proteins using Bacillus anthracis exosporium |
US8828464B2 (en) | 2008-07-09 | 2014-09-09 | University Of Hull | Whitened exine shells |
Also Published As
Publication number | Publication date |
---|---|
JP2004529616A (en) | 2004-09-30 |
KR20020061218A (en) | 2002-07-24 |
EP1353956A1 (en) | 2003-10-22 |
US20040180348A1 (en) | 2004-09-16 |
JP4128871B2 (en) | 2008-07-30 |
CN1264860C (en) | 2006-07-19 |
CN1486328A (en) | 2004-03-31 |
KR100810527B1 (en) | 2008-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7582426B2 (en) | Method for expression of proteins on spore surface | |
EP1902131B1 (en) | Phage display using cotranslational translocation of fusion polypeptides | |
KR100784261B1 (en) | Method for Cell Surface Displaying of Target Proteins Using Bacillus anthracis Exosporium | |
US9394344B2 (en) | Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof | |
EP0746621B1 (en) | Expression of proteins on bacterial surface | |
US20040180348A1 (en) | Method for surface display of proteins of genetic carriers | |
JP4180111B2 (en) | Materials and methods related to substance attachment and display on cell surfaces | |
US20040106118A1 (en) | Method for exposing peptides and polypeptides on the cell surface of bacteria | |
JP4458844B2 (en) | pgsBCA, vector for surface expression having a gene encoding poly-γ-glutamate synthetase, and method for microbial surface expression of target protein using the same | |
US8030064B2 (en) | Method for whole surrounding surface display of target proteins using bacterial exosporium | |
KR0185335B1 (en) | Surface expression vector and micro-organism surface expression method of protein using it | |
KR100690948B1 (en) | Method for Cell Surface Display of Target Proteins Using FadL of E. coli | |
US6040141A (en) | Bacteria for preparing stable fusion proteins and methods for detecting the same | |
Doi et al. | Screening of conformationally constrained random polypeptide libraries displayed on a protein scaffold | |
KR20110051094A (en) | Improved non-fusion spore display | |
Kim et al. | Method for expression of proteins on spore surface | |
KR102173586B1 (en) | Expression host strains for proteins display on spore surface and method for proteins display on spore surface | |
WO2008133433A2 (en) | Intact surface display of substances of interest | |
CN116348479A (en) | Bacterial pilus protein complex FimGt-DsF stable protein complex for the production of filamentous phage | |
Meyer et al. | Autodisplay: Functional Display of Active |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002716462 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002556629 Country of ref document: JP Ref document number: 028037529 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002716462 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10466208 Country of ref document: US |
|
WWR | Wipo information: refused in national office |
Ref document number: 2002716462 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002716462 Country of ref document: EP |